Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

113 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
One-year post-discharge resource utilization and treatment patterns of patients with acute coronary syndrome managed with percutaneous coronary intervention and treated with ticagrelor or prasugrel.
Simeone JC, Molife C, Marrett E, Frech-Tamas F, Effron MB, Nordstrom BL, Zhu YE, Keller S, Murphy BR, Nair KV, Vetrovec GW, Page RL 2nd, McCollam PL. Simeone JC, et al. Among authors: effron mb. Am J Cardiovasc Drugs. 2015 Oct;15(5):337-50. doi: 10.1007/s40256-015-0147-y. Am J Cardiovasc Drugs. 2015. PMID: 26359016
"Real-World" Comparison of Prasugrel With Ticagrelor in Patients With Acute Coronary Syndrome Treated With Percutaneous Coronary Intervention in the United States.
Larmore C, Effron MB, Molife C, DeKoven M, Zhu Y, Lu J, Karkare S, Lieu HD, Lee WC, Vetrovec GW. Larmore C, et al. Among authors: effron mb. Catheter Cardiovasc Interv. 2016 Oct;88(4):535-544. doi: 10.1002/ccd.26279. Epub 2015 Nov 18. Catheter Cardiovasc Interv. 2016. PMID: 26577386 Free PMC article.
Comparison of healthcare resource utilization and costs in patients hospitalized for acute coronary syndrome managed with percutaneous coronary intervention and receiving prasugrel or ticagrelor.
Molife C, Frech-Tamas F, DeKoven M, Effron MB, Karkare S, Zhu Y, Larmore C, Lu J, McCollam P, Marrett E, Vetrovec GW. Molife C, et al. Among authors: effron mb. J Med Econ. 2015;18(11):898-908. doi: 10.3111/13696998.2015.1060979. Epub 2015 Jul 10. J Med Econ. 2015. PMID: 26086414 Free article.
Sex-related differences in outcomes among men and women under 55 years of age with acute coronary syndrome undergoing percutaneous coronary intervention: Results from the PROMETHEUS study.
Chandrasekhar J, Baber U, Sartori S, Faggioni M, Aquino M, Kini A, Weintraub W, Rao S, Kapadia S, Weiss S, Strauss C, Toma C, Muhlestein B, DeFranco A, Effron M, Keller S, Baker B, Pocock S, Henry T, Mehran R. Chandrasekhar J, et al. Catheter Cardiovasc Interv. 2017 Mar 1;89(4):629-637. doi: 10.1002/ccd.26606. Epub 2016 May 24. Catheter Cardiovasc Interv. 2017. PMID: 27152497
Use of prasugrel vs clopidogrel and outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention in contemporary clinical practice: Results from the PROMETHEUS study.
Baber U, Sartori S, Aquino M, Kini A, Kapadia S, Weiss S, Strauss C, Muhlestein JB, Toma C, Rao SV, DeFranco A, Poddar KL, Chandrasekhar J, Weintraub W, Henry TD, Bansilal S, Baker BA, Marrett E, Keller S, Effron M, Pocock S, Mehran R. Baber U, et al. Am Heart J. 2017 Jun;188:73-81. doi: 10.1016/j.ahj.2017.02.013. Epub 2017 Feb 21. Am Heart J. 2017. PMID: 28577683
Associations Between Chronic Kidney Disease and Outcomes With Use of Prasugrel Versus Clopidogrel in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A Report From the PROMETHEUS Study.
Baber U, Chandrasekhar J, Sartori S, Aquino M, Kini AS, Kapadia S, Weintraub W, Muhlestein JB, Vogel B, Faggioni M, Farhan S, Weiss S, Strauss C, Toma C, DeFranco A, Baker BA, Keller S, Effron MB, Henry TD, Rao S, Pocock S, Dangas G, Mehran R. Baber U, et al. Among authors: effron mb. JACC Cardiovasc Interv. 2017 Oct 23;10(20):2017-2025. doi: 10.1016/j.jcin.2017.02.047. Epub 2017 Aug 2. JACC Cardiovasc Interv. 2017. PMID: 28780028 Free article.
Use of prasugrel and clinical outcomes in African-American patients treated with percutaneous coronary intervention for acute coronary syndromes.
Faggioni M, Baber U, Chandrasekhar J, Sartori S, Weintraub W, Rao SV, Vogel B, Claessen B, Kini A, Effron M, Ge Z, Keller S, Strauss C, Snyder C, Toma C, Weiss S, Aquino M, Baker B, Defranco A, Bansilal S, Muhlestein B, Kapadia S, Pocock S, Poddar KL, Henry TD, Mehran R. Faggioni M, et al. Catheter Cardiovasc Interv. 2019 Jul 1;94(1):53-60. doi: 10.1002/ccd.28033. Epub 2019 Jan 17. Catheter Cardiovasc Interv. 2019. PMID: 30656812
Incidence, predictors and impact of stroke on mortality among patients with acute coronary syndromes following percutaneous coronary intervention-Results from the PROMETHEUS registry.
Chandiramani R, Chen H, Aoi S, Giustino G, Claessen B, Sartori S, Aquino M, Sorrentino S, Cao D, Goel R, Kini A, Rao S, Weintraub W, Henry TD, Kapadia S, DeFranco A, Muhlestein JB, Toma C, Effron MB, Keller S, Baker BA, Pocock S, Baber U, Mehran R. Chandiramani R, et al. Among authors: effron mb. Catheter Cardiovasc Interv. 2020 Apr 1;95(5):885-892. doi: 10.1002/ccd.28369. Epub 2019 Jun 14. Catheter Cardiovasc Interv. 2020. PMID: 31197962
113 results